11.13
price up icon3.15%   0.34
after-market 시간 외 거래: 11.32 0.19 +1.71%
loading
전일 마감가:
$10.79
열려 있는:
$10.79
하루 거래량:
220.85K
Relative Volume:
0.67
시가총액:
$623.47M
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-8.6635
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
+2.20%
1개월 성능:
+4.41%
6개월 성능:
-31.72%
1년 성능:
+0.00%
1일 변동 폭
Value
$10.60
$11.32
1주일 범위
Value
$10.60
$11.58
52주 변동 폭
Value
$5.14
$29.46

Upstream Bio Inc Stock (UPB) Company Profile

Name
명칭
Upstream Bio Inc
Name
전화
781-208-2466
Name
주소
890 WINTER STREET, SUITE 200, WALTHAM
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
UPB's Discussions on Twitter

UPB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
UPB
Upstream Bio Inc
11.13 623.47M 2.22M -40.51M -46.53M -1.2847
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Upstream Bio Inc Stock (UPB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-05 개시 JP Morgan Overweight
2024-11-05 개시 Piper Sandler Overweight
2024-11-05 개시 TD Cowen Buy
2024-11-05 개시 William Blair Outperform

Upstream Bio Inc 주식(UPB)의 최신 뉴스

pulisher
Jun 16, 2025

Upstream Bio, Inc.’s Verekitug: A Promising Contender in the TSLPR Antibody Space - TipRanks

Jun 16, 2025
pulisher
Jun 15, 2025

Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency - Asianet Newsable

Jun 15, 2025
pulisher
Jun 15, 2025

Upstream Bio announces presentation of data on verekitug’s TSLP receptor - TipRanks

Jun 15, 2025
pulisher
Jun 15, 2025

Translational Data Illustrate a Mechanism of Greater - GlobeNewswire

Jun 15, 2025
pulisher
Jun 15, 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor - The Manila Times

Jun 15, 2025
pulisher
Jun 15, 2025

Upstream Bio Presents Pharmacology Modeling Data Supporting Verekitug's Potency over Tezepelumab at EAACI Congress - Nasdaq

Jun 15, 2025
pulisher
Jun 15, 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

Upstream Bio Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Better Energy Stock: TotalEnergies vs. Chevron - The Globe and Mail

Jun 11, 2025
pulisher
Jun 08, 2025

Upstream Bio (NASDAQ:UPB) Raised to Hold at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Upstream Bio, Inc. to Present TSLP Receptor Targeting Data for Verekitug at EAACI Congress 2025 - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

Upstream Bio to Present Mechanistic Insights into - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Breakthrough: Upstream Bio's Verekitug Demonstrates Enhanced Potency Over Current Asthma Treatments - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Upstream Bio to Reveal Latest Inflammatory Disease Treatment Progress at Major Goldman Sachs Conference - Stock Titan

Jun 04, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Invests $244,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

An Extremely Profitable Business Plans to Go Public. What Investors Need to Know. - The Globe and Mail

May 31, 2025
pulisher
May 26, 2025

Northern Trust Corp Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 26, 2025
pulisher
May 26, 2025

Jane Street Group LLC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 26, 2025
pulisher
May 20, 2025

Upstream Bio names new chief technology officer By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 20, 2025

Upstream Bio names new chief technology officer - Investing.com Australia

May 20, 2025
pulisher
May 20, 2025

Upstream Bio Appoints Stacy Price as Chief Technology Officer - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

Upstream Bio, Inc. Appoints Stacy Price as Chief Technology Officer to Lead Expansion of Technical Operations - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Upstream Bio Strengthens Leadership Team: Former Invivyd Executive Takes CTO Role for Critical Clinical Program - Stock Titan

May 20, 2025
pulisher
May 15, 2025

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN

May 15, 2025
pulisher
May 14, 2025

Tower Research Capital LLC TRC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 14, 2025
pulisher
May 10, 2025

Is Upstream Bio Inc (NASDAQ: UPB) A Good Investment Now? - Stocksregister

May 10, 2025
pulisher
May 10, 2025

Wells Fargo & Company MN Invests $149,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 10, 2025
pulisher
May 10, 2025

27,017 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Acquired by Barclays PLC - Defense World

May 10, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Invests $181,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 09, 2025
pulisher
May 09, 2025

Brokers Offer Predictions for Upstream Bio Q2 Earnings - Defense World

May 09, 2025
pulisher
May 07, 2025

Metric Analysis: Upstream Bio Inc (UPB)’s Key Ratios in the Limelight - DWinneX

May 07, 2025
pulisher
May 07, 2025

Upstream Bio Advances Verekitug in Clinical Trials - TipRanks

May 07, 2025
pulisher
May 06, 2025

Upstream Bio, Inc.: Strong Buy Rating Driven by Promising Drug Progress and Solid Financial Position - TipRanks

May 06, 2025
pulisher
May 06, 2025

Upstream Bio reports Q1 revenue $566k, consensus $326.25k - TipRanks

May 06, 2025
pulisher
May 06, 2025

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Transpire Bio Announces R&D and Manufacturing Expansion - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Upstream Bio Fast-Tracks Clinical Trials: Key Data Coming Earlier for Revolutionary Respiratory Drug - Stock Titan

May 06, 2025
pulisher
May 05, 2025

Invesco Ltd. Buys Shares of 15,602 Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

May 05, 2025
pulisher
May 02, 2025

1,734 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Purchased by Legal & General Group Plc - Defense World

May 02, 2025
pulisher
May 02, 2025

Gold Price and Miners Look Less Shiny as Global Trade Tensions Begin to Ease - The Globe and Mail

May 02, 2025
pulisher
Apr 29, 2025

JPMorgan Chase & Co. Acquires Shares of 47,792 Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Apr 29, 2025
pulisher
Apr 26, 2025

LPL Financial LLC Cuts Stake in Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (NYSEARCA:PDN) - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Geode Capital Management LLC Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World

Apr 26, 2025
pulisher
Apr 22, 2025

Upstream Bio Inc’s Banking’s 100-Day Moving Average at 11.87: Will the Stock Break Through? - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Medical Properties Trust Inc (MPW) Stock: Navigating a Year of Volatility - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

CytomX Therapeutics Inc’s Shares Reel: -10.73% Quarterly Revenue Decline Amid 60.07M Market Cap - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Philip Morris International Inc (PM) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 22, 2025

Upstream Bio Inc (UPB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Upstream Bio Inc 주식 (UPB) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
ORBIMED ADVISORS LLC
Director
Oct 15 '24
Buy
17.00
825,000
14,025,000
4,554,873
AI Upstream LLC
10% Owner
Oct 15 '24
Buy
17.00
1,175,000
19,975,000
1,175,000
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):